Biogen (BIIB) PT Raised to $390 at Bernstein
Get Alerts BIIB Hot Sheet
Price: $202.95 -2.4%
Rating Summary:
27 Buy, 16 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 24 | New: 9
Rating Summary:
27 Buy, 16 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 24 | New: 9
Join SI Premium – FREE
Bernstein analyst Aaron Gal raised the price target on Biogen (NASDAQ: BIIB) to $390.00 (from $370.00) while maintaining a Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Biogen (BIIB) PT Raised to $251 at H.C. Wainwright
- Thermax Ltd (TMX:IN) PT Lowered to INR5,100 at UBS
- Guggenheim Reiterates Buy Rating on Biogen (BIIB)
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Sanford C. BernsteinSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share